• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[ F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.阿尔茨海默病中 [F]AV-1451 对神经核和皮质的摄取聚类。
Ann Neurol. 2018 Feb;83(2):248-257. doi: 10.1002/ana.25142. Epub 2018 Feb 6.
2
MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous.MRI 和 flortaucipir 与阿尔茨海默病表型的关系具有异质性。
Ann Clin Transl Neurol. 2020 May;7(5):707-721. doi: 10.1002/acn3.51038. Epub 2020 Apr 15.
3
Tau PET in Alzheimer disease and mild cognitive impairment.tau PET 显像在阿尔茨海默病及轻度认知障碍中的应用。
Neurology. 2016 Jul 26;87(4):375-83. doi: 10.1212/WNL.0000000000002892. Epub 2016 Jun 29.
4
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.主观认知衰退与tau蛋白病的区域特异性关联,独立于整体β-淀粉样蛋白负荷。
JAMA Neurol. 2017 Dec 1;74(12):1455-1463. doi: 10.1001/jamaneurol.2017.2216.
5
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.阿尔茨海默病成像生物标志物的比较:使用[18F]氟比他哌正电子发射断层扫描进行淀粉样蛋白成像以及对内嗅皮质萎缩进行基于磁共振成像体素的分析。
Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7.
6
Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using F-AV-45 and F-AV-1451 PET.使用F-AV-45和F-AV-1451正电子发射断层扫描(PET)评估轻度认知障碍患者长期服用多奈哌齐治疗与脑区淀粉样蛋白和tau蛋白负荷之间的关联。
J Neurosci Res. 2022 Feb;100(2):670-680. doi: 10.1002/jnr.24995. Epub 2021 Dec 9.
7
Associations between quantitative [F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum.定量 [F]flortaucipir tau PET 与阿尔茨海默病谱中萎缩的相关性。
Alzheimers Res Ther. 2019 Jul 4;11(1):60. doi: 10.1186/s13195-019-0510-3.
8
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Tau正电子发射断层扫描(PET)模式反映了阿尔茨海默病的临床和神经解剖学变异性。
Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.
9
Quantitative F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.认知正常的老年人、轻度认知障碍患者及阿尔茨海默病患者的定量F-AV1451脑tau蛋白PET成像
Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019.
10
Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.匹兹堡化合物 B 和 AV-1451 正电子发射断层扫描评估进行性核上性麻痹中阿尔茨海默病的分子病理学。
Parkinsonism Relat Disord. 2018 Mar;48:3-9. doi: 10.1016/j.parkreldis.2017.12.016. Epub 2017 Dec 13.

引用本文的文献

1
Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer's disease using deep learning-derived saliency maps.基于脑tau正电子发射断层扫描,利用深度学习衍生的显著性图对阿尔茨海默病患者亚群进行识别和特征描述。
EJNMMI Phys. 2025 Jun 9;12(1):55. doi: 10.1186/s40658-025-00761-4.
2
Multimodal and longitudinal characterization of distinct tau and atrophy clusters in Alzheimer's disease spectrum.阿尔茨海默病谱系中不同tau蛋白和萎缩簇的多模态纵向特征分析。
Sci Rep. 2025 May 25;15(1):18142. doi: 10.1038/s41598-025-98338-9.
3
Heterogeneous tau deposition patterns in the preclinical stage link to domain-specific cognitive deficits.临床前阶段的异质性tau沉积模式与特定区域的认知缺陷相关。
Alzheimers Dement. 2025 May;21(5):e70153. doi: 10.1002/alz.70153.
4
Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer's Disease.tau蛋白成像:在阿尔茨海默病新诊断和治疗模式中的应用与实施
Geriatrics (Basel). 2025 Feb 14;10(1):27. doi: 10.3390/geriatrics10010027.
5
Novel Role of Pin1-Cis P-Tau-ApoE Axis in the Pathogenesis of Preeclampsia and Its Connection with Dementia.Pin1-顺式磷酸化tau蛋白-载脂蛋白E轴在子痫前期发病机制中的新作用及其与痴呆的关联
Biomedicines. 2024 Dec 26;13(1):29. doi: 10.3390/biomedicines13010029.
6
Deep learning-based patient stratification for prognostic enrichment of clinical dementia trials.基于深度学习的患者分层,用于临床痴呆症试验的预后富集。
Brain Commun. 2024 Dec 16;6(6):fcae445. doi: 10.1093/braincomms/fcae445. eCollection 2024.
7
Microscopy assessment of a fluorescence [F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions.一种荧光[F]氟替卡匹类似物(T726)的显微镜评估显示,其与3R和4R tau病变存在神经病理学重叠。
Alzheimers Dement. 2024 Dec;20(12):8758-8768. doi: 10.1002/alz.14330. Epub 2024 Oct 22.
8
Investigating the feasibility of F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological study.F-氟代托品PET成像在原发性年龄相关性tau蛋白病(PART)生前诊断中的可行性研究:一项观察性影像病理学研究。
Alzheimers Dement. 2024 Dec;20(12):8605-8614. doi: 10.1002/alz.14301. Epub 2024 Oct 17.
9
Novel Alzheimer's disease subtypes based on functional brain connectivity in human connectome project.基于人类连接组计划的功能脑连接的新型阿尔茨海默病亚型。
Sci Rep. 2024 Jun 27;14(1):14821. doi: 10.1038/s41598-024-65846-z.
10
Distinct biological property of tau in tau-first cognitive proteinopathy: Evidence by longitudinal clinical neuroimaging profiles and compared with late-onset Alzheimer disease.tau 在以 tau 为主的认知蛋白病中的独特生物学特性:纵向临床神经影像学特征的证据,并与晚发性阿尔茨海默病进行比较。
Psychiatry Clin Neurosci. 2024 Aug;78(8):446-455. doi: 10.1111/pcn.13680. Epub 2024 Jun 12.

本文引用的文献

1
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.广泛性脑 tau 及其与衰老、Braak 分期和阿尔茨海默病痴呆的关系。
Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.
2
Off-Target F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation.基底神经节中的非靶标 F-AV-1451 结合与年龄相关的铁积累有关。
J Nucl Med. 2018 Jan;59(1):117-120. doi: 10.2967/jnumed.117.195248. Epub 2017 Aug 3.
3
Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology.内嗅皮质:生前皮质厚度及死后神经原纤维缠结和淀粉样蛋白病理学
AJNR Am J Neuroradiol. 2017 May;38(5):961-965. doi: 10.3174/ajnr.A5133. Epub 2017 Mar 9.
4
Consensus classification of posterior cortical atrophy.后皮质萎缩的共识分类
Alzheimers Dement. 2017 Aug;13(8):870-884. doi: 10.1016/j.jalz.2017.01.014. Epub 2017 Mar 2.
5
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.体内[18F]AV-1451 tau PET 成像结果与典型和非典型阿尔茨海默病皮质萎缩和症状的关联。
JAMA Neurol. 2017 Apr 1;74(4):427-436. doi: 10.1001/jamaneurol.2016.5755.
6
Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome.阿尔茨海默病:年龄通过人类脑连接组对临床异质性的影响。
Alzheimers Dement (Amst). 2016 Dec 22;6:122-135. doi: 10.1016/j.dadm.2016.12.007. eCollection 2017.
7
A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity.用于测量阿尔茨海默病严重程度的皮质厚度和体积测量方法的大规模比较。
Neuroimage Clin. 2016 May 30;11:802-812. doi: 10.1016/j.nicl.2016.05.017. eCollection 2016.
8
Kinetic Modeling of the Tau PET Tracer F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects.在健康志愿者和阿尔茨海默病患者中tau PET 示踪剂 F-AV-1451 的动力学建模。
J Nucl Med. 2017 Jul;58(7):1124-1131. doi: 10.2967/jnumed.116.182881. Epub 2016 Dec 1.
9
[ F]AV-1451 tau positron emission tomography in progressive supranuclear palsy.[F] 1451 tau正电子发射断层扫描在进行性核上性麻痹中的应用
Mov Disord. 2017 Jan;32(1):124-133. doi: 10.1002/mds.26834. Epub 2016 Oct 27.
10
Defining imaging biomarker cut points for brain aging and Alzheimer's disease.定义脑老化和阿尔茨海默病的影像学生物标志物切点。
Alzheimers Dement. 2017 Mar;13(3):205-216. doi: 10.1016/j.jalz.2016.08.005. Epub 2016 Sep 30.

阿尔茨海默病中 [F]AV-1451 对神经核和皮质的摄取聚类。

[ F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

机构信息

Department of Radiology, Mayo Clinic, Rochester, MN.

Department of Neurology, Mayo Clinic, Rochester, MN.

出版信息

Ann Neurol. 2018 Feb;83(2):248-257. doi: 10.1002/ana.25142. Epub 2018 Feb 6.

DOI:10.1002/ana.25142
PMID:29323751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5821532/
Abstract

OBJECTIVE

To use a cluster analysis of [ F]AV-1451 tau-PET data to determine how subjects with Alzheimer's disease (AD) vary in the relative involvement of the entorhinal cortex and neocortex, and determine whether relative involvement of these two regions can help explain variability in age and clinical phenotype in AD.

METHODS

We calculated [ F]AV-1451 uptake in entorhinal cortex and neocortex in 62 amyloid-positive AD patients (39 typical and 23 atypical presentation). tau-PET (positron emission tomography) values were normalized to the cerebellum to create standard uptake value ratios (SUVRs). tau-PET SUVRs were log-transformed and clustered blinded to clinical information into three groups using K-median cluster analysis. Demographics, clinical phenotype, cognitive performance, and apolipoprotein e4 frequency were compared across clusters.

RESULTS

The cluster analysis identified a cluster with low entorhinal and cortical uptake (E /C ), one with low entorhinal but high cortical uptake (E /C ), and one with high cortical and entorhinal uptake (E /C ). Clinical phenotype differed across clusters, with typical AD most commonly observed in the E /C and E /C clusters, and atypical AD most commonly observed in the E /C cluster. The E /C cluster had an older age at PET and onset than the other clusters. Apolipoprotein e4 frequency was lower in the E /C cluster. The E /C cluster had the worst memory impairment, whereas the E /C cluster had the worst impairment in nonmemory domains.

INTERPRETATION

This study demonstrates considerable variability in [ F]AV-1451 tau-PET uptake in AD, but shows that a straightforward clustering based on entorhinal and cortical uptake maps well onto age and clinical presentation in AD. Ann Neurol 2018 Ann Neurol 2018;83:248-257.

摘要

目的

利用[F]AV-1451 tau-PET 数据的聚类分析,确定阿尔茨海默病(AD)患者在海马旁回和新皮质的相对受累程度存在何种差异,并确定这两个区域的相对受累程度能否有助于解释 AD 患者在年龄和临床表型方面的变异性。

方法

我们计算了 62 例淀粉样蛋白阳性 AD 患者(39 例为典型表现,23 例为非典型表现)的[F]AV-1451 摄取值。将 tau-PET(正电子发射断层扫描)值标准化到小脑,以创建标准摄取比值(SUV)。对 tau-PET SUV 进行对数转换,并在不了解临床信息的情况下,使用 K-中位数聚类分析将其盲分为 3 组。比较各组之间的人口统计学、临床表型、认知表现和载脂蛋白 E4 频率。

结果

聚类分析确定了一个低海马旁回和皮质摄取(E/C)的聚类,一个低海马旁回但高皮质摄取(E/C)的聚类,以及一个高皮质和海马旁回摄取(E/C)的聚类。临床表型在聚类间存在差异,典型 AD 最常见于 E/C 和 E/C 聚类,而非典型 AD 最常见于 E/C 聚类。E/C 聚类的 PET 和发病年龄比其他聚类更大。E/C 聚类的载脂蛋白 E4 频率较低。E/C 聚类的记忆障碍最严重,而 E/C 聚类的非记忆障碍最严重。

结论

本研究表明 AD 患者的[F]AV-1451 tau-PET 摄取存在较大差异,但表明基于海马旁回和皮质摄取图谱的简单聚类与 AD 患者的年龄和临床表现高度相关。Ann Neurol 2018;83:248-257。